Sandra M. Gurrola - 21 Jun 2025 Form 4 Insider Report for Ernexa Therapeutics Inc. (ERNA)

Reporting relationship: Sr. VP of Finance
Issuer ticker: ERNA
Reported as of: 21 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jul 2025, 20:00:05 UTC
Prior SEC filing: 10 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Sandra Gurrola

Key filing fact

Sandra M. Gurrola filed Form 4 for Ernexa Therapeutics Inc. (ERNA) on 07 Jul 2025.

Key facts

This page summarizes Sandra M. Gurrola's Form 4 filing for Ernexa Therapeutics Inc. (ERNA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Jul 2025, 20:00.

Change

Previous filing in this sequence was filed on 10 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001618457 Primary reporting owner

Gurrola Sandra M

Relationship: Sr. VP of Finance
Address: C/O ERNEXA THERAPEUTICS INC., 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE
Signature: /s/ Sandra Gurrola
Signature date: 07 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ERNA transaction

Common Stock

Options Exercise

Transaction value
Shares: +30
Change %: +38%
Price
Shares after: 110
Date: 21 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ERNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: +30
Change %
Price: $0.000000
Shares after: 0
Date: 21 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit converts into one share of common stock.

Footnote F2

On June 21, 2021, the reporting person was granted 118 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.